http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107281149-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2017-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107281149-B |
| titleOfInvention | Indobufen pharmaceutical composition and quality control method thereof |
| abstract | The invention relates to an indobufen pharmaceutical composition and a quality control method thereof. Specifically, the indobufen pharmaceutical composition comprises: 200 parts of indobufen, 30-50 parts of a saccharide diluent, 15-40 parts of a cellulose diluent, 5-15 parts of a disintegrating agent, 3-8 parts of an adhesive, 1-5 parts of a flow aid and 1-5 parts of a lubricant. The saccharide diluent is selected from: mannitol, sucrose, lactose, fructose, glucose, sorbitol, hydrates thereof, and combinations thereof. The invention also relates to a preparation method of the composition, a quality control method and pharmaceutical application thereof. The indobufen pharmaceutical composition can be used for arteriosclerotic ischemic cardiovascular diseases, ischemic cerebrovascular diseases and peripheral arterial diseases, dyslipidemia, venous thrombosis and diabetes, and can be used for preventing thrombosis in extracorporeal circulation surgery, and the pharmaceutical composition has excellent effects as described in the specification. |
| priorityDate | 2017-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.